The Chairman of the Pharmaceutical Authority participates in the opening of the expansion of a company to support the manufacture of dialysis supplies
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, participated in the event organized by a company on the occasion of the opening of its new industrial expansions in the second industrial zone in the 6th of October City, within the framework of the Egyptian Pharmaceutical Authority’s keenness to support vital industries, enhance the capabilities of local manufacturing to meet the needs of the local market and open extensive export horizons, in line with the vision of Egypt 2030.
The event witnessed the attendance of The number of & nbsp; from senior Egyptian and international officials, led by Lieutenant General Kamel, Deputy Prime Minister for Industrial Development and Minister of Transport and Industry, Dr. Hisham State, Chairman of the Egyptian Authority for Unified Purchase, Supply, Medical Supply and Medical Technology Department, Dr. Nahid Youssef, Chairman of the Industrial Development Authority, Gareth Bailey, British Ambassador to the Arab Republic of Egypt, Thomas Brennan, Chairman of the Board of Directors A company. Markets. The vitality for the treatment of kidney patients, on top of which is filters and dialysis solutions, is a top priority within the authority’s efforts to secure the needs of patients and ensure the continuity of availability, and stressed the importance of expanding the local manufacturing of this group of medical products, as it is one of the basic elements in the health care system, and a national necessity in light of the increasing challenges of the sector.
& nbsp; Special attention to local production projects that contribute to reducing dependence on import and promoting national industrial capabilities, in a manner that ensures the achievement of sustainable pharmaceutical security, and that such projects enhance Egypt’s position as a leading industrial center in the field of medical industries, and represents a successful model for constructive cooperation between the public and private sectors, and opens the way for effective partnerships with international institutions with experience, in a way that contributes to the development of the care system Health and achieving sustainable health security. And smoothly in the distribution. Quality is identical to the latest international specifications, as the company reviewed its future vision and its most prominent initiatives in the field of social responsibility, which includes improving health care services and upgrading the quality of patients ’life inside Egypt. Increasing the production capacity of the company by 30 percent, and Thomas Brennan explained that these expansions were funded by pumping direct investments from the parent company in Britain amounting to 16 million euros, which reflects the confidence of the foreign investor in the strength of the Egyptian drug market. Medical in line with the approved organizational standards.
